Chapter 7. Small Molecule Endothelin Receptor Antagonists
- 1 January 1994
- book chapter
- Published by Elsevier
- Vol. 29, 65-71
- https://doi.org/10.1016/s0065-7743(08)60720-4
Abstract
No abstract availableThis publication has 59 references indexed in Scilit:
- Endothelins in the control of cardiovascular and renal functionThe Lancet, 1993
- Renal actions of endothelinKidney International, 1993
- Effects of endothelin receptor antagonist on cyclosporine-induced vasoconstriction in isolated rat renal arterioles.Journal of Clinical Investigation, 1993
- BQ-123, a peptidic endothelin ETA receptor antagonist, prevents the early cerebral vasospasm following subarachnoid hemorrhage after intracisternal but not intravenous injectionLife Sciences, 1993
- Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptorLife Sciences, 1992
- Increased plasma endothelin-1 in acute ischemic stroke.Stroke, 1992
- A potent and specific agonist, Suc-[Glu9,Ala11,15]-endothelin-1(8-21), IRL 1620, for the ETB receptorBiochemical and Biophysical Research Communications, 1992
- The solution structure of a cyclic endothelin antagonist, BQ‐123, based on1H–1H and13H–1H three bond oupling constantsFEBS Letters, 1992
- The conformation of endothelin-1 in aqueous solution: NMR-Derived constraints combined with distance geometry and molecular dynamics calculationsBiochemical and Biophysical Research Communications, 1991
- An endothelin receptor (ETA) antagonist isolated from Streptomyces misakiensisBiochemical and Biophysical Research Communications, 1991